1. Home
  2. ONMD vs SLGL Comparison

ONMD vs SLGL Comparison

Compare ONMD & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$1.27

Market Cap

71.4M

Sector

N/A

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

N/A

Current Price

$42.00

Market Cap

117.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONMD
SLGL
Founded
2006
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.4M
117.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ONMD
SLGL
Price
$1.27
$42.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$50.00
AVG Volume (30 Days)
2.6M
15.3K
Earning Date
11-14-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$494,000.00
$18,970,000.00
Revenue This Year
N/A
$121.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
62.04
52 Week Low
$0.30
$4.02
52 Week High
$4.22
$52.26

Technical Indicators

Market Signals
Indicator
ONMD
SLGL
Relative Strength Index (RSI) 40.57 57.44
Support Level $1.46 $38.30
Resistance Level $2.30 $44.43
Average True Range (ATR) 0.24 3.59
MACD -0.01 0.02
Stochastic Oscillator 0.47 68.45

Price Performance

Historical Comparison
ONMD
SLGL

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's technology has provens the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade, image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols, paving the way for Real World Evidence.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: